Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion type Assertion NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_head.
- NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.
- NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion evidence source_evidence_literature NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.
- NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion SIO_000772 12738753 NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.
- NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion wasDerivedFrom befree-2016 NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.
- NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion wasGeneratedBy ECO_0000203 NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.